期刊
PEERJ
卷 3, 期 -, 页码 -出版社
PEERJ INC
DOI: 10.7717/peerj.936
关键词
Lappaconitine; Leukemia; Bone pain; Analgesia
资金
- Zhejiang Provincial Nature Science Foundation of China [LY14C050003]
- National Natural Science Foundation of China [31470071]
- New Century 151 Talent Project of Zhejiang Province
- 521 Talent Foundation of Zhejiang Sci-Tech University, Zhejiang Provincial Top Key Discipline of Biology
Bone pain is a common and severe symptom in cancer patients. The present study employed a mouse model of leukemia bone pain by injection K562 cells into tibia of mouse to evaluate the analgesic effects of lappacontine. Our results showed that the lappaconitine treatment at day 15, 17 and 19 could effectively reduce the spontaneous pain scoring values, restore reduced degree in the inclined-plate test induced by injection of K562 cells, as well as restore paw mechanical withdrawal threshold and paw withdrawal thermal latency induced by injection of K562 cells to the normal levels. Additionally, the molecular mechanisms of lappaconitine's analgesic effects may be related to affect the expression levels of endogenous opioid system genes (POMC, PENK and MOR), as well as apoptosis-related genes (Xiap, Smac, Bim, NF-kappa B and p53). Our present results indicated that lappaconitine may become a new analgesic agent for leukemia bone pain management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据